Kalaris Therapeutics, Inc. (KLRS)

NASDAQ: KLRS · Real-Time Price · USD

6.56

-0.25 (-3.67%)

At close: Mar 20, 2026, 4:00 PM EDT

6.57

+0.01 (0.15%)

After-hours: Mar 20, 2026, 4:10 PM EDT

Kalaris Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	98.05	1.64	90.12	106.09	201.66
Short-Term Investments	19.93	-	93.82	127.7	46.46
Cash & Short-Term Investments	117.98	1.64	183.94	233.8	248.12
Cash Growth	7098.41%	-99.11%	-21.32%	-5.77%	-30.37%
Other Receivables	-	-	0.21	0.16	0.05
Total Trade Receivables	-	-	0.21	0.16	0.05
Other Current Assets	0.83	0.97	3.49	9.1	5.18
Total Current Assets	118.81	2.61	187.64	243.05	253.35
Net Property, Plant & Equipment	1.48	-	2.19	32.56	31.29
Other Long-Term Assets	1.45	0.41	0.97	1.46	1.95
Total Assets	121.74	6.16	190.8	277.08	286.59
Accounts Payable	1.28	1.56	6.76	3	8.36
Accrued Expenses	-	-	10.09	13.99	20.15
Short-Term Debt	-	19.54	-	-	-
Current Portion of Leases	0.32	-	10.78	7.17	6.59
Other Current Liabilities	-	1.41	0.74	0.18	2.75
Total Current Liabilities	9.71	24.7	28.37	24.34	37.85
Long-Term Debt	32.08	32.08	-	-	-
Long-Term Leases	1.13	-	16.65	28.22	23.48
Total Long-Term Liabilities	33.21	32.08	16.65	28.22	23.48
Total Liabilities	42.92	56.78	45.02	52.56	61.33
Common Stock	0	-	-	0.01	0.01
Additional Paid-in Capital	238.81	19.95	802.04	690.75	522.48
Accumulated Other Comprehensive Income	0.01	-	-0.06	-0.47	-0.16
Retained Earnings	-160	-116.56	-656.19	-465.78	-297.07
Total Common Shareholders' Equity	78.81	-96.62	145.78	224.52	225.27
Minority Interest	-	46	-	-	-
Shareholders' Equity	78.81	-50.62	145.78	224.52	225.27
Total Liabilities & Equity	121.74	6.16	190.8	277.08	286.59
Total Debt	33.52	51.62	27.43	35.39	30.07
Net Cash (Debt)	84.46	-49.98	156.51	198.41	218.05
Net Cash Growth	-	-	-21.12%	-9.01%	-37.27%
Net Cash Per Share	5.53	-37.41	34.59	59.53	79.88
Book Value	78.81	-96.62	145.78	224.52	225.27
Book Value Per Share	5.16	-72.32	32.22	67.37	82.53
Tangible Book Value	78.81	-96.62	145.78	224.52	225.27
Tangible Book Value Per Share	5.16	-72.32	32.22	67.37	82.53

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q